CORD-19:0d5be5a4268da7c08b478ca36721d46bd67bbe69 / 16669-16951 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T112","span":{"begin":0,"end":282},"obj":"Sentence"},{"id":"TextSentencer_T112","span":{"begin":0,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"MiR-141 was also found to be overexpressed in ovarian and colorectal cancers [23, 24] and downregulated in prostate, hepatocellular, renal cell carcinoma and in gastric cancer tissues [25] [26] [27] [28] raising a controversial issue about the role of miR-141 in cancer progression."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T4","span":{"begin":133,"end":153},"obj":"Phenotype"},{"id":"T5","span":{"begin":161,"end":175},"obj":"Phenotype"},{"id":"T6","span":{"begin":263,"end":269},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0005584"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0012126"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"MiR-141 was also found to be overexpressed in ovarian and colorectal cancers [23, 24] and downregulated in prostate, hepatocellular, renal cell carcinoma and in gastric cancer tissues [25] [26] [27] [28] raising a controversial issue about the role of miR-141 in cancer progression."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T115","span":{"begin":58,"end":76},"obj":"Disease"},{"id":"T116","span":{"begin":133,"end":153},"obj":"Disease"},{"id":"T118","span":{"begin":144,"end":153},"obj":"Disease"},{"id":"T119","span":{"begin":161,"end":175},"obj":"Disease"},{"id":"T120","span":{"begin":169,"end":175},"obj":"Disease"},{"id":"T121","span":{"begin":263,"end":269},"obj":"Disease"},{"id":"T44973","span":{"begin":58,"end":76},"obj":"Disease"},{"id":"T78669","span":{"begin":133,"end":153},"obj":"Disease"},{"id":"T43479","span":{"begin":144,"end":153},"obj":"Disease"},{"id":"T63194","span":{"begin":161,"end":175},"obj":"Disease"},{"id":"T99791","span":{"begin":169,"end":175},"obj":"Disease"},{"id":"T83599","span":{"begin":263,"end":269},"obj":"Disease"}],"attributes":[{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0005575"},{"id":"A116","pred":"mondo_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/MONDO_0005086"},{"id":"A117","pred":"mondo_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/MONDO_0005549"},{"id":"A118","pred":"mondo_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/MONDO_0004993"},{"id":"A119","pred":"mondo_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/MONDO_0001056"},{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A89322","pred":"mondo_id","subj":"T44973","obj":"http://purl.obolibrary.org/obo/MONDO_0005575"},{"id":"A46818","pred":"mondo_id","subj":"T78669","obj":"http://purl.obolibrary.org/obo/MONDO_0005086"},{"id":"A35904","pred":"mondo_id","subj":"T78669","obj":"http://purl.obolibrary.org/obo/MONDO_0005549"},{"id":"A41805","pred":"mondo_id","subj":"T43479","obj":"http://purl.obolibrary.org/obo/MONDO_0004993"},{"id":"A2330","pred":"mondo_id","subj":"T63194","obj":"http://purl.obolibrary.org/obo/MONDO_0001056"},{"id":"A50135","pred":"mondo_id","subj":"T99791","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A79531","pred":"mondo_id","subj":"T83599","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"MiR-141 was also found to be overexpressed in ovarian and colorectal cancers [23, 24] and downregulated in prostate, hepatocellular, renal cell carcinoma and in gastric cancer tissues [25] [26] [27] [28] raising a controversial issue about the role of miR-141 in cancer progression."}